by Kevin Whittlesey, Ph.D., DHC Principal
“Effective project and program management will have a substantial positive impact on the quality, time, and cost of cell and gene therapy product development. Although the terms ‘program management’ and ‘project management’ are often used interchangeably…”
by former Dark Horse Ryan Duffy
“The end goal of Knowledge and Technology Transfer activities associated with a manufacturing process and analytical assays is moving the production, testing, and release of a Drug Product from one manufacturing location to another, while…”
by Phil Bowles, MSc., DHC Principal
"Successful delivery of a new Cell and Gene Therapy (CGT) facility relies on effective project management throughout its lifecycle to meet quality, financial and schedule goals. CGT capital projects require significant investment of money, time and human capital to construct or modify a clinical or commercial manufacturing facility. The new or expanded manufacturing capacity delivered by the project will inevitably be..."
by Heather Todd, M.S., DHC Senior Consultant
by Sara Masterson, MBA, DHC Principal
by Michael Kinzie, DHC Principal